Eiger BioPharmaceuticals, Inc. Annual Operating Margin in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Eiger BioPharmaceuticals, Inc. annual/quarterly Operating Margin history and growth rate from 2021 to 2023.
  • Eiger BioPharmaceuticals, Inc. Operating Margin for the quarter ending December 31, 2022 was -688 %, a 8.54% decline year-over-year.
  • Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2023 was -455 %, a 33.8% increase from 2022.
  • Eiger BioPharmaceuticals, Inc. annual Operating Margin for 2022 was -688 %, a 8.54% decline from 2021.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -455 +233 +33.8% Jan 1, 2023 Dec 31, 2023
2022 -688 -54.1 -8.54% Jan 1, 2022 Dec 31, 2022
2021 -634 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.